ArticleCancers2019

Overactive IGF1/Insulin Receptors and NRASQ61R Mutation Drive Mechanisms of Resistance to Pazopanib and Define Rational Combination Strategies to Treat Synovial Sarcoma.

Cinzia Lanzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.